"Bayes Affinity Fingerprints" Improve Retrieval Rates in Virtual Screening and Define Orthogonal Bioactivity Space: When Are Multitarget Drugs a Feasible Concept?
暂无分享,去创建一个
Andreas Bender | Meir Glick | Jeremy L. Jenkins | John W. Davies | James H. Nettles | Zhan Deng | Z. Deng | A. Bender | J. Jenkins | M. Glick | J. Davies | J. Nettles
[1] David M. Rocke,et al. Predicting ligand binding to proteins by affinity fingerprinting. , 1995, Chemistry & biology.
[2] G. Bemis,et al. The properties of known drugs. 1. Molecular frameworks. , 1996, Journal of medicinal chemistry.
[3] G. S. Johnson,et al. An Information-Intensive Approach to the Molecular Pharmacology of Cancer , 1997, Science.
[4] John M. Barnard,et al. Chemical Similarity Searching , 1998, J. Chem. Inf. Comput. Sci..
[5] Hans Briem,et al. Flexsim-X: A Method for the Detection of Molecules with Similar Biological Activity , 2000, J. Chem. Inf. Comput. Sci..
[6] U. Lessel,et al. In vitro and in silico affinity fingerprints: Finding similarities beyond structural classes , 2000 .
[7] Hans Briem,et al. Flexsim-R: A virtual affinity fingerprint descriptor to calculate similarities of functional groups , 2002, J. Comput. Aided Mol. Des..
[8] P. Beroza,et al. Chemoproteomics as a basis for post-genomic drug discovery. , 2002, Drug discovery today.
[9] Tudor I. Oprea,et al. Chemical space navigation in lead discovery. , 2002, Current opinion in chemical biology.
[10] K. Baumann. Distance Profiles (DiP): A translationally and rotationally invariant 3D structure descriptor capturing steric properties of molecules , 2002 .
[11] Dragos Horvath,et al. Predicting ADME properties and side effects: the BioPrint approach. , 2003, Current opinion in drug discovery & development.
[12] N. Stiefl,et al. Mapping property distributions of molecular surfaces: algorithm and evaluation of a novel 3D quantitative structure-activity relationship technique. , 2003, Journal of medicinal chemistry.
[13] G. S. Gill,et al. Molecular surface point environments for virtual screening and the elucidation of binding patterns (MOLPRINT) , 2004 .
[14] J. Jenkins,et al. A 3D similarity method for scaffold hopping from known drugs or natural ligands to new chemotypes. , 2004, Journal of medicinal chemistry.
[15] Robert P. Sheridan,et al. Calculating Similarities between Biological Activities in the MDL Drug Data Report Database , 2004, J. Chem. Inf. Model..
[16] Richard Morphy,et al. From magic bullets to designed multiple ligands. , 2004, Drug discovery today.
[17] R. Glen,et al. Molecular similarity: a key technique in molecular informatics. , 2004, Organic & biomolecular chemistry.
[18] Andreas Bender,et al. Similarity Searching of Chemical Databases Using Atom Environment Descriptors (MOLPRINT 2D): Evaluation of Performance , 2004, J. Chem. Inf. Model..
[19] P. Willett,et al. Comparison of topological descriptors for similarity-based virtual screening using multiple bioactive reference structures. , 2004, Organic & biomolecular chemistry.
[20] Andrew C. Good,et al. Measuring CAMD technique performance: A virtual screening case study in the design of validation experiments , 2004, J. Comput. Aided Mol. Des..
[21] Jérôme Hert,et al. Comparison of Fingerprint-Based Methods for Virtual Screening Using Multiple Bioactive Reference Structures , 2004, J. Chem. Inf. Model..
[22] Muthukumarasamy Karthikeyan,et al. General Melting Point Prediction Based on a Diverse Compound Data Set and Artificial Neural Networks , 2005, J. Chem. Inf. Model..
[23] Andreas Bender,et al. A Discussion of Measures of Enrichment in Virtual Screening: Comparing the Information Content of Descriptors with Increasing Levels of Sophistication , 2005, J. Chem. Inf. Model..
[24] A. Fliri,et al. Biospectra analysis: model proteome characterizations for linking molecular structure and biological response. , 2005, Journal of medicinal chemistry.
[25] P. Willett,et al. Enhancing the effectiveness of similarity-based virtual screening using nearest-neighbor information. , 2005, Journal of medicinal chemistry.
[26] Qiang Zhang,et al. Scaffold hopping through virtual screening using 2D and 3D similarity descriptors: ranking, voting, and consensus scoring. , 2006, Journal of medicinal chemistry.
[27] J. Jenkins,et al. Prediction of Biological Targets for Compounds Using Multiple‐Category Bayesian Models Trained on Chemogenomics Databases. , 2006 .
[28] John P. Overington,et al. Can we rationally design promiscuous drugs? , 2006, Current opinion in structural biology.
[29] A. Bender,et al. Circular fingerprints: flexible molecular descriptors with applications from physical chemistry to ADME. , 2006, IDrugs : the investigational drugs journal.
[30] Andreas Bender,et al. Analysis of Activity Space by Fragment Fingerprints, 2D Descriptors, and Multitarget Dependent Transformation of 2D Descriptors , 2006, J. Chem. Inf. Model..
[31] Robert C. Glen,et al. Chapter 9 Molecular Similarity: Advances in Methods, Applications and Validations in Virtual Screening and QSAR , 2006, Annual Reports in Computational Chemistry.